Lauren M. Green, OncLive

home / authors / lauren-m-green-onclive

Articles

‘Smart' Alkylator TH-302 Shows Clinical Benefit in Early Multiple Myeloma Trial

‘Smart' Alkylator TH-302 Shows Clinical Benefit in Early Multiple Myeloma Trial

Lauren M. Green, OncLive
June 2nd 2014

Study assesses the safety and tolerability of TH-302 in combination with dexamethasone.

Read More

It's All About Coverage

It's All About Coverage

Lauren M. Green, OncLive
March 12th 2013

The Affordable Care Act will expand coverage and may open the door to elevated roles for pharmacists, former Health and Human Services Secretary Donna Shalala argued in a speech at the Miami Breast Cancer Conference.

Read More

Site Logo

It's All About Coverage

Lauren M. Green, OncLive
March 12th 2013

The Affordable Care Act will expand coverage and may open the door to elevated roles for pharmacists, former Health and Human Services Secretary Donna Shalala argued in a speech at the Miami Breast Cancer Conference.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD